tiprankstipranks
Plus Therapeutics CMO Dr. LaFrance Resignation Announced
Company Announcements

Plus Therapeutics CMO Dr. LaFrance Resignation Announced

Don't Miss our Black Friday Offers:

Plus Therapeutics (PSTV) has shared an update.

Plus Therapeutics, Inc. is set to experience a change in its executive team as Dr. Norman LaFrance, the Chief Medical Officer, has tendered his resignation, which will take effect on June 12, 2024.

Find detailed analytics on PSTV stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyPlus Therapeutics presents updated progress from its ReSPECT-LM Phase 1 trial
TheFlyPlus Therapeutics to present FORESEE clinical trial summary
TheFlyPlus Therapeutics subsidiary to present data on CNSide CSF Assay Platform
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App